ClinicalTrials.Veeva

Menu

E-cigarette Harm Reduction Among PLWHA in South Africa

NYU Langone Health logo

NYU Langone Health

Status

Not yet enrolling

Conditions

Tobacco Smoking

Treatments

Behavioral: Counseling
Other: Nicotine Replacement Therapy (NRT)
Other: E-Cigarette (EC)

Study type

Interventional

Funder types

Other

Identifiers

NCT06169813
22-00868

Details and patient eligibility

About

The purpose of this pilot randomized controlled trial study aims to address the unmet need for feasible and efficacious strategies for reducing combustible cigarette (CC) use among people living with HIV/AIDS (PLWHA) in South Africa, which has the potential to significantly improve the health and long-term survival of PLWHA CC smokers. Using the proposed intervention, based on the Information-Motivation-Behavioral Skills (IMB), and a simultaneous embedded mixed methods approach, the investigators will evaluate a telehealth program targeting CC harm reduction, comparing E-cigarettes (EC) to nicotine replacement therapy (NRT) that is enhanced by integrating ecological momentary intervention (EMI) texting. As such, this proposal will significantly build research capacity in South Africa to conduct telehealth tobacco treatment interventions using innovative EMI approaches enhancing participants' engagement, as well as state-of-the art evaluation approaches.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult PLWHA CC smokers;
  • Speaks Afrikaans, or Xhosa, or English;
  • reports daily CC smoking (≥ 5 CPD);
  • Owns any type of mobile phone;
  • interested in reducing CC smoking but not necessarily trying to quit;
  • Receives HIV/AIDS care in one of the eight selected clinics follow-up rates.

Exclusion criteria

  • are pregnant or breastfeeding;
  • unable to provide consent;
  • used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo);
  • currently engaged in an attempt to quit CC smoking;
  • current major depressive or manic episode, current psychotic disorder, past-year suicide attempt, or current suicidal ideation with plan or intent. plan or intent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 3 patient groups

Control (Quit-Line Referral)
Active Comparator group
Description:
Participants will receive referral to the existing South African Quitline. Participants will receive information to contact the Quitline if participants so choose, in addition to ecological momentary assessment (EMA) texting orientation.
Treatment:
Behavioral: Counseling
Nicotine Replacement Therapy (NRT)
Experimental group
Description:
In addition to phone counseling + ecological momentary intervention (EMI) texting, participants will receive combination NRT (daily patches and lozenges).
Treatment:
Behavioral: Counseling
Other: Nicotine Replacement Therapy (NRT)
Electronic Cigarette (EC)
Experimental group
Description:
In conjunction with phone counseling + EMI texting, participants will receive the VUSE "Solo" EC.
Treatment:
Other: E-Cigarette (EC)
Behavioral: Counseling

Trial contacts and locations

1

Loading...

Central trial contact

Justin McClendon; Omar El-Shahawy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems